Browse by Poster Title

• 5
• P-580
  5-alpha Reductase Inhibitors and the Risk of Anemia Among Men with Benign Prostatic Hyperplasia
  Favorite
• A
• P-345
  A Comparison of Data Mining Algorithms Using Different Drug Classifications for Signal Identification
  Favorite
• P-390
  A Contemporary Characterization of Patients with Non-valvular Atrial Fibrillation Starting Oral Anticoagulants in Quebec, Canada
  Favorite
• P-076
  A Controlled 1-year Mirror-image Study of the Effect of Paliperidone Palmitate on Hospitalization in the Treatment of Schizophrenia in China
  Favorite
• P-378
  A Counterfactual Approach to Minimize Channeling Bias in Post-market Safety Surveillance
  Favorite
• P-269
  A Descriptive Retrospective Cohort Study to Evaluate the Incidence of Severe COVID 19 Outcomes Among sars-cov-2 Infected Patients in the United States
  Favorite
• P-563
  A New United States Database for Pharmacoepidemiology Studies in Type 2 Diabetes Mellitus: The IMEDS Distributed Database
  Favorite
• P-101
  A Pharmacovigilance Analysis of Restless Legs Syndrome Treatments and Suicidality
  Favorite
• P-338
  A Proof of Concept Study to Test the E-CORE Network in Studying Safety and Effectiveness of Treatments in COVID-19 Patients
  Favorite
• P-117
  A Rapid Review on the Adherence to Evidence-based Medical Therapy in Peripheral Artery Disease Patients
  Favorite
• P-354
  A Retrospective Database Study to Evaluate Incidence of Influenza and Influenza-like Illness (ILI) Among Rheumatoid Arthritis (RA) Patients Taking Conventional Synthetic Disease Modifying Antirheumatic Drugs (csDMARD)
  Favorite
• P-278
  A Review of the Sampling Methodology Used in Studies Evaluating the Effectiveness of Risk Minimization Measures in Europe
  Favorite
• P-083
  A Survey of HLA-B 1502 Genotype Testing on Carbamazepine New User in a Regional Teaching Hospital in Taiwan, 2019
  Favorite
• P-275
  A Systematic Literature Review of the Epidemiology, Health-related Quality of Life and Economic Burden, Including Disease Pathways and Treatment Patterns of Relapsed/refractory Classical Hodgkin Lymphoma
  Favorite
• P-404
  A Systematic Review of Global Oncology Treatment Practice and Modifications During COVID-19
  Favorite
• P-259
  A Systematic Review of Non-small Cell Lung Cancer Treatment-related Cardiotoxicity
  Favorite
• P-365
  A Tenfold Increase in the Rate of Adverse Drug Event Reports in Saudi Arabia
  Favorite
• P-220
  Absence Benefit Use and Payment Trends Among Short- and Long-term Disability, and Workers' Compensation for Employees with Any of 20 Top Agency for Healthcare Research and Quality Conditions
  Favorite
• P-227
  Absence Benefit Utilization, Duration of Leaves, and Payments Vary by Benefit and over Time for Short- and Long-term Disability and Workers' Compensation for Employees with Headaches and Migraines in the United States
  Favorite
• P-012
  Adherence to Anti-dementia Medicine: A South African Database Analysis
  Favorite
• P-086
  Adherence to Mesalazine and Identification of Patients with Ulcerative Colitis in Healthcare Administrative Databases of Tuscany (Italy)
  Favorite
• P-119
  Adverse Drug Reactions and Its Evaluation in Saudi Arabia; Retrospective Observational Study
  Favorite
• P-171
  Adverse Events Associated with Remdesivir in covid-19 Patients: Evaluation of Spontaneous Reports Submitted to US FDA Adverse Event Reporting System (FAERS)
  Favorite
• P-173
  Adverse Events in covid-19 Patients Treated with Lopinavir/ritonavir: Exploration of US FDA Adverse Event Reporting System (FAERS) Reports
  Favorite
• P-229
  Adverse Events in NSCLC Patients Treated with Docetaxel Monotherapy
  Favorite
• P-342
  Adverse Events of the COVID-19 Vaccines Reported to the Vaccine Adverse Event Reporting System (VAERS), December 14, 2020 -january 22, 2021
  Favorite
• P-383
  Adverse Reactions to Dolutegravir Reported to the National HIV & Tuberculosis Health Care Worker Hotline in South Africa
  Favorite
• P-246
  An Evaluation of Injurious Falls and Fall-risk-increasing-drug (FRID) Prescribing Behaviors in a Nationally Representative Sample & the Pharmacist’s Role in Fall Prevention
  Favorite
• P-122
  An Evidence-based Evaluation of Clinical Medicine Use Indicators in Children
  Favorite
• P-620
  An Open algorithm to Pre-process Free Text Self-reported Medications Data in UK Biobank
  Favorite
• P-277
  An Updated Structured Review of the Epidemiology, Guidelines, and Real-world Treatment Patterns for Relapsed/refractory Primary Mediastinal Large B-cell Lymphoma
  Favorite
• P-240
  Analysis of COVID-19 Patient Experiences Reported Through Social Media
  Favorite
• P-093
  Analysis of Voluntarily Reported Medication Errors: An Excerpt from a Teaching Hospital in a Developing Country
  Favorite
• P-470
  Antibiotic Resistance Pattern and Treatment Outcomes Among Empyema Thoracis Patients: A Cross-sectional Study
  Favorite
• P-412
  Antimicrobial Resistance in Endodontic Infections in Latin America (MICROBE-DENT): Systematic Review
  Favorite
• P-237
  Antimicrobial Use in Patients Diagnosed with Chronic Kidney Disease Admitted in the Internal Medical Wards at Dr George Mukhari Academic Hospital
  Favorite
• P-251
  Anti-osteoporosis Treatment After a Major Osteoporotic Fracture Is Often Lacking
  Favorite
• P-370
  Antithrombotic Therapy Prescription Patterns in the Secondary Prevention of Stroke in Patients with Atrial Fibrillation: Findings from a Real-world, Population-based Study
  Favorite
• P-033
  Any Link Between Polypharmacy and the Risk of Mortality Among Patients with Chronic Heart Failure Newly Diagnosed? A Nested Case-control Study
  Favorite
• P-635
  Are Biologic Medicines Getting a FAERS Go? A Case Study of Rituximab and Pyoderma Gangrenosum (PG)
  Favorite
• P-547
  Aromatase Inhibitors Associated with Sjogren’s Syndrome: A Disproportionality Analysis in Spontaneous Reporting Database
  Favorite
• P-406
  Assessing the Impact of Pharmacist-led Anticoagulation Clinic Within a Tertiary Care Setting in Saudi Arabia: A Retrospective Cross-sectional Study ‎
  Favorite
• P-363
  Assessing the Post Marketing Experience of Clopidogrel and Major Cardiovascular Events After PCI in Saudi Arabia Using the Saudi Food and Drug Authority (SFDA) Spontaneous Reporting System
  Favorite
• P-081
  Assessment of Adherence to Deferasirox Risk Minimization Measures in Saudi Arabia
  Favorite
• P-359
  Assessment of Antipsychotic Use and Other Predictors Associated with Mortality in Patients with Delirium: A Population-based Nested Case Control Study
  Favorite
• P-167
  Assessment of Drug Related Problems at a Tertiary Care Teaching Hospital
  Favorite
• P-478
  Assessment of Drug-drug Interactions Among Geriatric Patients in Community Setting
  Favorite
• P-241
  Assessment of Health-related Quality of Life in Adults with Asthma by Asthma Severity
  Favorite
• P-026
  Assessment of Predictors of Fractures in German Older Adults Using a Large Population Sample
  Favorite
• P-029
  Assessment of the National Pharmacovigilance System in Nepal Using the Indicator Based Pharmacovigilance Assessment Tool (IPAT)
  Favorite
• P-504
  Association Between Anticholinergic Burden of Medications and Emergency Care in the Elderly Assisted in the Brazilian Prymary Care Setting
  Favorite
• P-621
  Association Between DPP-4 Inhibitors and COVID-19 Related Outcomes Among Patients with Type 2 Diabetes
  Favorite
• P-231
  Association Between Non-adherence to Endocrine Therapy and the Risk of Recurrence Among Breast Cancer Survivors: A Systematic Literature Review
  Favorite
• P-585
  Association Between Oral Anticoagulants and Risk of Dementia in Patients with Non-valvular Atrial Fibrillation
  Favorite
• P-496
  Association Between Persistence to Treatment After Percutaneous Coronary Intervention and Clinical Outcomes in Acute Coronary Syndrome Patients: A Multicenter Study in Indonesia
  Favorite
• P-386
  Association Between Primary Care Provider Payment Models and Adherence to Anticoagulation in a Sample of Patients with Atrial Fibrillation
  Favorite
• P-271
  Association Between the Multiple Myeloma Treatments and Vascular Adverse Events in Taiwanese Multiple Myeloma Patients: A Population-based Cohort Study
  Favorite
• P-007
  Association Between the Use of Mood Stabilizers and Risk of Trauma Among Patients with Bipolar Disorder
  Favorite
• P-586
  Association Between the Use of Oral Anticoagulant and Risk of Adverse COVID-19 Outcomes: An Opensafely Analysis
  Favorite
• P-088
  Association of Inflammatory Bowel Disease with the Risk of Parkinson’s Disease: A Meta-analysis of Real-world Evidence
  Favorite
• P-399
  Association of Ondansetron Use and Subsequent Acute Kidney Injury in Critical Care
  Favorite
• P-505
  Automating Individual Case Safety Report Identification Within Scientific Literature Using Natural Language Processing
  Favorite
• P-465
  Avoidable Public Expenditures with Selected Antineoplastic Drugs for Breast Cancer in Brazil
  Favorite
• P-417
  Awareness of Pregnant Women About the Spontaneous Adverse Drug Reaction Reporting System in Bulgaria- a Pilot Study
  Favorite
• B
• P-073
  Baloxavir Marboxil vs Neuraminidase Inhibitors Prescription on Subsequent Medical Resource Utilization Among School-aged Children with Influenza: Analysis of Two Consecutive Seasons in Japan
  Favorite
• P-273
  Beneficial Effect of Mild Drug-induced Liver Injury for Patients with Tuberculosis Undergoing First-line Anti-tuberculosis Therapy
  Favorite
• P-299
  Benefits Analysis of Pharmacists Intervention Multi-drug Integration in Chronic Patients
  Favorite
• P-549
  Benzodiazepine Use, Nonmedical Use, and Overdose in the U.S
  Favorite
• P-468
  Biliary Toxicity of Immune Checkpoint Inhibitors: A Pharmacovigilance Study Through FDA Adverse Event Reporting System Database
  Favorite
• C
• P-183
  Can We Really Trust the Findings of the COVID-19 Research? Quality Assessment of the Randomized Controlled Trials Published on COVID-19
  Favorite
• P-182
  Can We Really Trust the Findings of the COVID-19 Research? Quality Assessment of the Research Articles Published on COVID-19
  Favorite
• P-298
  Carboplatin Appropriateness and Rationality Assessment
  Favorite
• P-303
  Cardiovascular Safety Assessment of Febuxostat and Allopurinol in the Real World: A Retrospective Cohort Study
  Favorite
• P-381
  Cardiovascular Safety Profile of Romosozumab: A Pharmacovigilance Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS)
  Favorite
• P-373
  Cefoperazone and the Risk of Bleeding: A Systematic Review and Network Meta-analysis
  Favorite
• P-424
  Challenges in Studying COVID-19 Treatments in Real-world Hospital Datasets: A Case Study of Tocilizumab
  Favorite
• P-481
  Characteristics of Asymptomatic Heart Failure Patients with Reduced Ejection Fraction in a Large Us-based Real-world Cohort
  Favorite
• P-405
  Characteristics of Patients Initiating Spiriva Respimat for Asthma in the UK
  Favorite
• P-392
  Characteristics of Patients with Idiopathic Pulmonary Fibrosis (IPF) Initiating Nintedanib or Pirfenidone Treatment Compared with Untreated Patients in the US
  Favorite
• P-311
  Characterization of Polypharmacy in Middle-aged and Elderly Adults in the UK: An Analysis of 0.5 million People in UK Biobank
  Favorite
• P-100
  Characterization of Real-world Data Sources to Support Observational Studies of Biologics, Including Biosimilars in Oncology
  Favorite
• P-449
  Characterizing “long-covid” Using Real World Data: Post-discharge Clinical Course Among Patients Initially Hospitalized for COVID-19
  Favorite
• P-097
  Characterizing Patients Using Abuse-deterrent Formulations of Extended-release Opioid Analgesics
  Favorite
• P-190
  Characterizing Real-world Treatment Patterns Among Patients Hospitalized Due to sars-cov-2
  Favorite
• P-430
  Chronic Obstructive Pulmonary Disease and Drug-resistant Pseudomonas in Patients Hospitalized with Community-acquired Bacterial Pneumonia
  Favorite
• P-254
  Chronic Prescription Medications and Prevalence of Polypharmacy in Survivors of Childhood Cancer
  Favorite
• P-622
  Claims-based Algorithm for Defining Asthma GINA Steps in US Healthcare Database
  Favorite
• P-090
  Classification of Gabapentinoids as Controlled Drugs Reduced Gabapentinoid Prescriptions in Primary Care in England
  Favorite
• P-089
  Clinical and Cost-saving Effects of the Drug Utilization Review Modernization Pilot Project in Inpatient and Outpatient Settings in Korea
  Favorite
• P-018
  Clinical Characteristics and Biomarkers of sars-cov-2 Infection in Patients Treated with Remdesivir in Hospital - A Population Based Cohort Study
  Favorite
• P-577
  Clinical Characteristics of Pediatric Patients Hospitalized with COVID-19 in an Electronic Health Record Database
  Favorite
• P-394
  Clinical Effectiveness of Anti-tnf, Non-anti-tnf and Tofacitinib in the Treatment of Rheumatoid Arthritis
  Favorite
• P-121
  Clinical Notes versus Diagnosis Codes in Identification and Characterization of Women with Endometriosis
  Favorite
• P-276
  Clinical Outcomes Among Relapsed/refractory (R/R) Adult and Pediatric Classical Hodgkin’s Lymphoma (cHL) Patients: A Global Systematic Literature Review (SLR)
  Favorite
• P-050
  Cohort Study Assessing Angioedema Risk in Black Heart Failure Patients Using Angiotensin-converting Enzyme Inhibitors in the United States– Interim Results
  Favorite
• P-114
  Comedication of Opioids with Benzodiazepines, Gabapentinoids Among Caregivers of Children with Special Healthcare Needs
  Favorite
• P-175
  Community Pharmacists Managed Patient Safety Program with Minimal Patient Contact for Elderly Patients in Ajman, United Arab Emirates
  Favorite
• P-569
  Comorbidities Associated with Insomnia Stratified by Age and Sex
  Favorite
• P-463
  Comparative Analysis on the Evolution of Antimicrobial Resistance Surveillance and Governance Between China and the United States
  Favorite
• P-096
  Comparative Clinical Effectiveness of Secuquinumabe and Anti-tnf Agents in the Treatment of Psoriasic Arthritis
  Favorite
• P-032
  Comparative Effectiveness and Safety of Low versus High Dose Rivaroxaban and Apixaban for Atrial Fibrillation: A Propensity Score-matched Cohort Study
  Favorite
• P-164
  Comparative Effectiveness and Safety of Prasugrel versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Transluminal Coronary Angioplasty
  Favorite
• P-419
  Comparative Risk of Delirium Associated with Oxybutynin and Solifenacin in Older Adults
  Favorite
• P-493
  Comparison and Contrast of Antibiotic Utilization and Outcomes in Hospital-acquired Pneumonia (HAP), Ventilated HAP (vHAP) and Ventilator Associated Pneumonia (VAP) in the United States
  Favorite
• P-380
  Comparison of 21-year Sex-specific Fracture Incidence Rates Between Type 1 and Type 2 Diabetics and Non-diabetics in Denmark (1997 – 2017)
  Favorite
• P-105
  Comparison of Pediatric Antibiotherapy in Primary Care: Low vs. High Prescribers
  Favorite
• P-201
  Comparison of Quality of Life Between Men and Women with Chronic Liver Diseases Using Chronic Liver Disease Questionnaire (CLDQ): A Meta-analysis
  Favorite
• P-115
  Comparison of Rheumatic Patients Across Body Mass Index Categories
  Favorite
• P-325
  Comparison of Safety Profiles by Chronic Health Conditions in Korean Adults with Egg-based Inactivated Quadrivalent Influenza Vaccines (QIV, GC3110A)
  Favorite
• P-435
  Comparison of Safety Signals Between Selective Serotonin-reuptake Inhibitors (SSRI) and Serotonin–norepinephrine Reuptake Inhibitors (SNRI) Employing Fda Adverse Event Reporting System (FAERS) Database
  Favorite
• P-632
  Comparison of the Incidence of Acute Pancreatitis Among New Users of Fluoxetine, Citalopram, and Other Selective Serotonin Reuptake Inhibitors: A Danish Register-based Cohort Study
  Favorite
• P-017
  Comparison of the Incidence of Bleeding Between Anti-influenza Drugs Among Outpatients for the Influenza Virus Infection: A Retrospective Study Using an Employment-based Health Insurance Claims Database in Japan
  Favorite
• P-128
  Comparisons of Effect Estimates of 12 Prescribing Cascades Using Prescription Sequence Symmetry Analysis
  Favorite
• P-524
  Conduction Disorders/dysrhythmias and Hydroxychloroquine in Rheumatoid Arthritis
  Favorite
• P-139
  Consumption Patterns of Chronic Medication During the COVID-19 Pandemic in Portugal
  Favorite
• P-120
  Coronavirus Disease 2019 in Saudi Arabia: A Nationwide Epidemiological Characterization Study
  Favorite
• P-134
  Cost Considerations of Dermatological Care in Jordan: A Cross-sectional Study
  Favorite
• P-133
  Cost-related Nonadherence for Prescription Medications: A Cross-sectional Study in Jordan
  Favorite
• P-508
  COVID-19 Symptom Severity Among Smokers: Insights from a Direct-to-community Registry
  Favorite
• P-351
  COVID-19 Treatment Approaches Among Hospitalized Patients in a National Healthcare System
  Favorite
• P-451
  Creating High Quality External Control Arms from RWD in Support of Regulatory Decision Making
  Favorite
• D
• P-135
  Depression and Anxiety in Patients with Cancer: Prevalence and Risk Factors: A Cross-sectional Study
  Favorite
• P-431
  Designing Epidemiological Studies to Estimate the Incidence of Thrombosis in Patients with Antiphospholipid Syndrome with History of Recurrent Thrombotic Events
  Favorite
• P-274
  Detecting Drug-drug Interaction Signal of Concomitant Use of Tramadol and SSRI Using Korea Adverse Event Reporting System Database
  Favorite
• P-322
  Detecting Signals for the Vaccine-vaccine Interaction Between Pneumococcal Vaccines and Influenza Vaccines Using the Korea Adverse Event Reporting System (KAERS)
  Favorite
• P-265
  Detecting Tizanidine and cyp1a2 Inhibitor Interaction Signals Using the Food and Drug Administration’s Adverse Event Reporting System
  Favorite
• P-467
  Determinants of COVID-19 Self-protection Behaviors of Thai People: A Cross-sectional Survey
  Favorite
• P-212
  Determinants of Intravenous Admixture Preparation Errors: A Prospective Observational Study
  Favorite
• P-102
  Determining the Accuracy of Developing New User Cohorts Using Electronic Health Record Data
  Favorite
• P-072
  Deterministic Linkage of Pregnant Mothers and Their Newborns in Integrated US Insurance Claims and Electronic Health Record Data
  Favorite
• P-558
  Development and Validation of a Prediction Model for Mortality in Patients with Hip Fracture: Population-based Cohort Study
  Favorite
• P-486
  Diabetes Medication Use Is Associated with Higher Grade and Increased Probability of Muscle-invasive Tumour Disease in Patients with Urothelial Carcinoma
  Favorite
• P-059
  Diagnostic Delay, Effectiveness and Safety Outcomes in a Real-world Cohort of Patients with Crohn’s Disease: Data from Administrative Databases in Tuscany, Italy
  Favorite
• P-150
  Differential Demographic and Clinical Characteristics Between MMR Vaccinated and Unvaccinated Children in South Korea
  Favorite
• P-312
  Disease Prevalence, Comorbidities, and Medication Utilization Among Patients with Opioid Use Disorder in the US
  Favorite
• P-014
  Dispensing Patterns of Antithrombotic Agents in South Africa with Specific Focus on the Direct Oral Anticoagulants (DOACs): A Database Analysis
  Favorite
• P-124
  Disruptions in Rheumatology Care and the Rise of Telehealth in Response to the COVID19 Pandemic in a Community Practice-based Network
  Favorite
• P-301
  Drug Use Evaluation of Cephalosporins in Patients with Culture Report of Enterococcus Faecalis or Enterococcus Faecium
  Favorite
• P-304
  Drug Use Evaluation of Fentanyl Buccal Soluble Film
  Favorite
• P-306
  Drug Use Evaluation of Vytorin
  Favorite
• P-302
  Drug Utilization Evaluation for the Treatment of Vulvovaginal Candidiasis
  Favorite
• P-296
  Drug Utilization Evaluation of Duloxetine
  Favorite
• P-305
  Drug Utilization Evaluation of Pregabalin
  Favorite
• P-295
  Drug Utilization Pattern of Antiepileptic Drugs in Pregnancy and the Outcome of Offspring in Asia Population
  Favorite
• P-011
  Drug Utilization Research in Africa: overview of Demographic and Socioeconomic Profile, Health Systems and Epidemiology
  Favorite
• P-330
  Drug-drug Interactions in a Kidney Transplant Patient with COVID-19: A Case Report
  Favorite
• P-289
  Drug-induced Liver Injury Associated with Lopinavir-ritonavir in Patients with COVID-19: A Disproportionality Analysis of U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) Data
  Favorite
• P-376
  Dupilumab Use and Potential Risk of Alopecia Areata: A Systematic Review
  Favorite
• E
• P-546
  Early Assessment of the Impact of the COVID-19 Era on Charlson Score
  Favorite
• P-522
  Early Parkinson’s Disease: Association of Baseline Fatigue, Pain and Sleep Disorders with Disease Progression
  Favorite
• P-337
  E-CORE - Setting up a European Network for Real World COVID-19 Studies
  Favorite
• P-503
  Effect of Anti-dementia Drugs on and Potential Racial/ethnic Disparities in Satisfaction with Quality of Care Among Older Adults with Alzheimer’s Disease and Related Dementias
  Favorite
• P-518
  Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Liver Disease: A Population-based Cohort Study
  Favorite
• P-633
  Effectiveness and Safety of Direct Oral Anticoagulants versus Warfarin in Patients with Valvular Atrial Fibrillation: A Population-based Cohort Study
  Favorite
• P-266
  Effectiveness and Safety of Edoxaban and Warfarin in Nonvalvular Atrial Fibrillation Patients: A Meta-analysis of Real-world Studies
  Favorite
• P-352
  Effectiveness and Safety of Extended Anticoagulation in Patients with Venous Thromboembolism: A Retrospective Cohort Study
  Favorite
• P-411
  Effectiveness of a Six-month Isoniazid as Tuberculosis Preventive Therapy in People Living with HIV in Eritrea: A Retrospective Cohort Study
  Favorite
• P-138
  Effectiveness of Sacubitril/valsartan versus Aldosterone Antagonists for Prevention of Heart Failure-related and All-cause Hospitalization in Heart Failure with Reduced Ejection Fraction
  Favorite
• P-459
  Efficacy and Effectiveness of Mobile Health Technologies to Improve Breastfeeding: Scoping Review
  Favorite
• P-476
  Efficacy of the Optimeds Tool for Multidisciplinary Medication Review in Belgian Nursing Homes
  Favorite
• P-042
  Epidemiology of Coexisting Obesity and Heart Failure with Preserved Ejection Fraction in the United States
  Favorite
• P-046
  Epidemiology of COVID-19 in Adults with Asthma
  Favorite
• P-048
  Epidemiology of COVID-19 in Adults with Chronic Obstructive Pulmonary Disease
  Favorite
• P-045
  Epidemiology of COVID-19 in Adults with Diabetes Mellitus
  Favorite
• P-044
  Epidemiology of COVID-19 in Children
  Favorite
• P-039
  Epidemiology of Interstitial Lung Disease in Medically Treated US Population
  Favorite
• P-321
  Epidemiology of Treatment Resistant Depression in the US
  Favorite
• P-209
  Estimates of Malnutrition Associated with Chronic Kidney Disease Globally and Its Contrast with India: A Systematic Review and Meta-analysis
  Favorite
• P-488
  Estimates of Paracetamol Poisoning in Brazil: Analysis of Official Records
  Favorite
• P-196
  Estimation of Adverse Events Scale Relating Korean Medicine in Korea
  Favorite
• P-426
  Evaluating the Completeness of Electronic Health Records in Identifying Nonfatal Cardiovascular Events in Taiwan
  Favorite
• P-527
  Evaluating the Impact of New Prescribing Restrictions for Publicy-subsidised Proton Pump Inhibitors in Australia: An Interrupted Time Series Analysis
  Favorite
• P-107
  Evaluating the Use of Prescription Sequence Symmetry Analysis as a Pharmacovigilance Tool: A Scoping Review
  Favorite
• P-329
  Evaluation of Albumin Utilization in a Major Teaching Hospital in Iran Before and After Guideline Implementation
  Favorite
• P-307
  Evaluation of Availability of Information on Risk Factors in Reports of Adverse Drug Reactions in a Pharmacovigilance Database
  Favorite
• P-489
  Evaluation of Chirality for Withdrawn Drugs
  Favorite
• P-395
  Evaluation of Drain Use During Total Knee Replacement Associated with Health Outcomes and Healthcare Utilization
  Favorite
• P-264
  Evaluation of Esketamine Adverse Event from the FAERS Database and Published Case Reports
  Favorite
• P-627
  Evaluation of Machine-learning Algorithms for Predicting Direct-acting Antiviral Treatment Failure in Patients with Chronic Hepatitis C: An HCV-TARGET Analysis
  Favorite
• P-331
  Evaluation of Potential Drug-drug Interactions Among Patients of the Nephrology and Kidney Transplant Wards of a Major Teaching Hospital
  Favorite
• P-052
  Evaluation the Pattern of Treatment in Inflammatory Bowel Disease: Before and After Approved Policy on Biologicals
  Favorite
• P-281
  Examining the Evolving Pandemic: Trends in COVID-19 Severity for Hospitalized COVID-19 Patients over Time
  Favorite
• P-267
  Excess Risk of Anaphylaxis with Concomitant Use of Qingkailing Injection and Cefotaxime Sodium: An Example of Novel Herbal-drug Interaction
  Favorite
• P-317
  Experimenting with County-level COVID-19 Data as a Substitute for Demographic Information
  Favorite
• P-194
  External Control Arms to Contextualise Single Arm Clinical Trials – Propensity Score Methods Can Be Inconsistent
  Favorite
• F
• P-293
  Factors Associated with Different Dosage Forms of Disease-modifying Agents in Older Adults with Multiple Sclerosis
  Favorite
• P-515
  Factors Predictive of Treatment Success of Novel Disease-modifying Anti-rheumatic Drugs (DMARDS) in Patients with Inflammatory Arthritis
  Favorite
• P-477
  Feasibility and Acceptability of the Optimeds Tool for Multidisciplinary Medication Review in Belgian Nursing Homes
  Favorite
• P-536
  Flares After Hydroxychloroquine Reduction or Discontinuation in a Multinational Inception Cohort of Systemic Lupus
  Favorite
• P-027
  Four Competing Definitions of Morphine Equivalence Insidiously Inhibit Evidence Synthesis
  Favorite
• P-095
  Fracture Outcome Coding in Observational Osteoporosis Drug Effects Studies: A Scoping Review
  Favorite
• P-382
  Fracture Risk Following the Initiation Of antihypertensive Therapy Amongst Frail Elderly People: A Self-controlled Case Series analysis
  Favorite
• P-574
  Frequency, Characteristics, and Subsequent Treatment (Tx) of Real-world Patients (pts) Who Discontinue Hedgehog Inhibitors (HHIs) as First-line (1L) Systemic Tx for Advanced Basal Cell Carcinoma (aBCC)
  Favorite
• P-480
  From Contact Coverage to Effective Coverage of Community Care for Patients with Severe Mental Disorders: A Real-world Investigation from Italy
  Favorite
• G
• P-623
  Generating Hypotheses About Never-smoking Lung Cancer Risk Factors Using Large Primary Care Databases
  Favorite
• P-056
  Genetic Heterogeneity Patterns of Electronic Medical Record (EMR)-Derived Race Groups in a Deidentified Clinico-genomic Database (CGDB)
  Favorite
• P-291
  Global Antiplatelet Sales Trend: A Focus on P2Y12 Inhibitors from 2008 to 2018
  Favorite
• P-285
  Global Symptom Improvement for Patients with Aromatic L-amino Acid Decarboxylase Deficiency Using Individual Participant Data
  Favorite
• P-548
  Graphical Representation of Multiple Quantitative Bias Analysis Scenarios for Unmeasured Confounding
  Favorite
• H
• P-023
  Handling with Vaccine Type Missing Data in a Dynamic Cohort to Assess the Link Between Time-varying Vaccination and an Autoimmune Disease
  Favorite
• P-407
  Health Economics Analysis and Quality of Life of Patients Undergoing Primary Total Knee Arthroplasty (TKA) from China ATTUNE® Study
  Favorite
• P-243
  Healthcare Resource Use in a US Claims Database During the Early Period of the COVID-19 Pandemic
  Favorite
• P-458
  Health-related Quality of Life in Older Adults with Concomitant Opioid and Skeletal Muscle Relaxant Use in a National Cohort of Older Adults
  Favorite
• P-284
  High Adherence and Sustained Virologic Response Among Vulnerable People Initiating an Hcv Treatment at a Community-based Nurse-led Clinic: A Cohort Study
  Favorite
• P-316
  How COVID-19 Randomized Controlled Trials Reported on Demographic and Clinical Characteristics
  Favorite
• P-170
  How Government Health Insurance Coverage of Novel Anti-cancer Medicines Benefited Cancer Patients in China: A Retrospective Analysis of the Insurance Claim Data
  Favorite
• P-629
  How Under-coded Is Pediatric Hypertension?: Comparison of Claims and Electronic Health Record (EHR) Data
  Favorite
• P-310
  Hypnotic Drug Use and Underlying Diagnoses Among Adolescents in Norway
  Favorite
• I
• P-286
  Identification of a Diagnostically Complex Condition, Polycystic Ovarian Syndrome, in a Population-based Cohort Using Electronic Health Record Data
  Favorite
• P-452
  Identification of Appropriate Safety Metrics in Long-term Studies
  Favorite
• P-177
  Identification of Novel Safety Signals of sglt2 Inhibitors: A Pharmacovigilance Analysis of the Usfda and Global Adverse Event Reporting Databases
  Favorite
• P-176
  Identification of Novel Safety Signals of sglt2 Inhibitors: Analysis of Us Fda and Global Safety Databases
  Favorite
• P-554
  Identification of Patients with Nonalcoholic Steatohepatitis (NASH) in an Electronic Health Record (EHR) Database
  Favorite
• P-127
  Identifying Dipeptidyl peptidase-4 Inhibitor Users with Sufficient Data Completeness in Electronic Health Records
  Favorite
• P-400
  Imbalanced Data Bias in Logistic Regression to Estimate Treatment Effects: Results from a Virtual Patient Cohort Simulation
  Favorite
• P-160
  Impact Analysis of the COVID-19 Epidemic on the Patterns of Access to Medicines of Patients with Common Chronic Diseases in Beijing
  Favorite
• P-500
  Impact of Chronic Diseases on the Adherence to Guidelines for the Treatment of Urinary Tract Infection in Quebec, Canada
  Favorite
• P-087
  Impact of COVID-19 Outbreak on Antidepressants Utilization: A Real-word Drug-utilization Study Based on Tuscany Healthcare Administrative Databases
  Favorite
• P-403
  Impact of H. pylori Eradication Therapy After the Introduction of Endoscopic Screening for Gastric Cancer in Japan
  Favorite
• P-514
  Impact of Increasing Enrollment Requirements in Administrative Claims Data
  Favorite
• P-628
  Impact of Multimorbidity Subgroups on the Health Care Use, Expenditures, and Clinical Outcomes Among Patients with Tuberculosis: A Population-based Cohort Analysis
  Favorite
• P-372
  Impact of Statin Treatment on COVID-19 Risk and Outcome – a Potential Positive Effect on Survival
  Favorite
• P-247
  Impact of the COVID-19 Pandemic on Routine Clinical Management of Patients with Neurological Conditions: A Retrospective Cohort Study in UK Primary Care (CPRD)
  Favorite
• P-015
  Impact of the Introduction of Generic Equivalents on Memantine Consumption in South Africa Using the ATC/DDD Methodology
  Favorite
• P-575
  Impact of Treatment Sequence on Survival Outcome in Patients with a Second Treatment Line for Metastatic Castration-resistant Prostate Cancer: A New-user Design in the French Nationwide Claims Database
  Favorite
• P-159
  Impacts of Pharmacists’ Intervention on Drug-related Problems in Treatment for Pediatric Outpatients in Vietnam
  Favorite
• P-534
  Impacts of Prescription Drug Monitoring Program on Patients with Cancer
  Favorite
• P-069
  Improving Accuracy for Prospective Pregnancy Registry Enrollment Targets
  Favorite
• P-421
  Inadequate Response Rates and Associated Factors to Psoriasis Therapies Using a Claims-based Algorithm
  Favorite
• P-413
  Incentive Structure of Employer Health Insurance and Impact on Patient Drug Use and Cost of Accessing the Private Primary Healthcare System
  Favorite
• P-071
  Inception to Conception: A Conceptual Framework for Characterizing Pharmacoepidemiologic Data Sources. a Study from the Conception Project
  Favorite
• P-230
  Incidence and Outcomes of Mature B-cell NHL in the US Pediatric Population, 2000-2017
  Favorite
• P-450
  Incidence in Pharmacoepidemiology – New on the Drug versus New on the Class of Drugs
  Favorite
• P-428
  Incidence of Angioedema After Initiation of Angiotensin-converting Enzyme Inhibitors in Adults with Heart Failure
  Favorite
• P-003
  Incidence Rates (IR) and IR Ratios of Alzheimer’s Disease in Patients with Cataract Compared to the General Population: Analyses Using the Clinical Practice Research Datalink (CPRD)
  Favorite
• P-387
  Individual Case Safety Reports Analysis for Patients with Diabetes Mellitus on Insulin in Africa and the Middle East
  Favorite
• P-401
  Inpatient Readmission and Oral Antiplatelet Adherence for Patients with Coronary Artery Disease
  Favorite
• P-596
  Insights from a Review of Publicly Available Information on Post Authorisation Safety Studies (PASS)
  Favorite
• P-094
  Intravenous Vancomycin Use at Discharge and 90-day Risk of Readmission or Death
  Favorite
• P-471
  Intravitreal Anti-vascular Endothelial Growth Factors Use in France: Cross-sectional and Longitudinal Nationwide Observational Studies
  Favorite
• K
• P-162
  Key Opportunities and Future Direction for Drug Utilization Research in Africa
  Favorite
• P-131
  Knowledge and Awareness of the General Population and Healthcare Providers About Retinoblastoma: It Is Time to Know the Glow
  Favorite
• L
• P-250
  Lessons from a Post-authorisation Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Practice in Four Countries
  Favorite
• P-568
  Limited Time Interval Between Symptomatic Presentation in Primary Care and Colorectal Cancer Diagnosis
  Favorite
• P-217
  Long- and Short-term Disability and Workers' Compensation Trends for Employees with Bone Diseases
  Favorite
• P-225
  Long- and Short-term Disability and Workers' Compensation Trends for Employees with Eye (Ophthalmic) Conditions in the United States
  Favorite
• P-226
  Long- and Short-term Disability and Workers' Compensation Trends for Employees with Gastrointestinal (Digestive System) Conditions in the United States
  Favorite
• P-224
  Long- and Short-term Disability and Workers' Compensation Trends for Employees with Systemic Lupus Erythematosus or Connective Tissue Disorders in the United States
  Favorite
• P-222
  Long- and Short-term Disability, Workers' Compensation and Prevalence Trends for Employees with Mental Disorders in the United States
  Favorite
• P-223
  Long- and Short-term Disability, Workers' Compensation and Prevalence Trends for Employees with Substance Abuse Mental Disorders in the United States
  Favorite
• P-189
  Low Rates of Bone-active Medication Utilization from 2013-2017 by Provider Type for Beneficiaries Aged 65+ with Medicare Part D
  Favorite
• P-550
  Low-dose Acetylsalicylic Use Shows Protective Association with Alzheimer’s Disease Incidence: Results from Two Large Prospective Cohort Studies
  Favorite
• M
• P-432
  Machine Learning Applied to SEER Data for Prediction of Breast Cancer Specific Survival
  Favorite
• P-353
  Matching Study Design to Prescribing Intention: The Prevalent New User Design in Opioid Research
  Favorite
• P-528
  Measuring the Impact of Marketing Authorisation Withdrawal and Revocation on Public Health in France, Germany and UK
  Favorite
• P-597
  Medical Cannabis Authorization and Drugs and Other Substances Use Disorders: longitudinal Cohort Study
  Favorite
• P-442
  Medication Error Concept and Reporting Practices in Saudi Arabia: A Nationwide Study Among Healthcare Professionals
  Favorite
• P-344
  Medication Regimen Complexity Among Older Adults Admitted to Home Hospice
  Favorite
• P-397
  Medicines Use by Professors at a Brazilian Public University During the covid-19 Pandemic: Findings and Implications
  Favorite
• P-564
  Melatonin Use Among Children, Adolescents, and Young Adults. a Danish Nationwide Drug Utilization Study
  Favorite
• P-103
  Methodologic Challenges and Considerations for the Collection of Dietary Intake Data in Real-world Populations
  Favorite
• P-341
  Methodological Considerations Related to the Use of Primary and Secondary Care Data in Identifying a Cohort of Moderate to Severe Psoriasis Patients in the UK
  Favorite
• P-339
  Methods and Practical Considerations in Use of an External Control to Assess Potential Drug Risk
  Favorite
• P-109
  Misuse of Antimicrobials in the Rural Population of a District in South India
  Favorite
• P-576
  Modeling Drug Treatment Effects on Breast Cancer in the Setting of Differential Screening
  Favorite
• P-248
  Modeling Parasite Clearance Curves in a Cohort to Compare Quinine and Artesunate for the Treatment of Pediatric Cerebral Malaria
  Favorite
• P-234
  Molecular Epidemiology Study of Interferon Gamma (IFN-γ) Expression in Urothelial Bladder Cancer (UBC)
  Favorite
• P-360
  Monitoring of Adverse Drug Reaction-related Parameters in Children, Youth and Young Adults Prescribed Antipsychotic Drugs by General Practitioners
  Favorite
• P-061
  Montelukast and Nightmare – Further Characterisation Using Data from Vigibase
  Favorite
• P-062
  Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study Among Healthcare Professionals and Patients in Croatia, the Netherlands, and the UK
  Favorite
• P-005
  Multimorbidity Measures from Health Administrative Data: A Systematic Review
  Favorite
• P-525
  Mycophenolate and Azathioprine Are Associated with Risk of Hospitalized Viral Respiratory Infection in Rheumatoid Arthritis and Systemic Lupus
  Favorite
• N
• P-142
  Non-persistence with Statins in Diabetic and Non-diabetic Patients with Transient Ischemic Attack
  Favorite
• P-288
  Novel Glucose-lowering Agents and Cardiorenal Benefits: Absence of Racial/ethnic Diversity in Clinical Trials
  Favorite
• P-448
  Nsaids and Paracetamol-induced Hepatotoxicity: A Systematic Review and Meta-analysis of Observational Studies
  Favorite
• P-242
  Nsaids and Risk of Myocardial Infarction in Patients with No Major Risk Factors: A Nested Case-control Study in the UK Clinical Practice Research Datalink
  Favorite
• P-408
  Nucala Exposure in Women of Childbearing Age and in Pregnant Women in US Claims Data, 2016-2019
  Favorite
• O
• P-520
  Off-label Day-of-surgery Gabapentinoids and Prolonged Opioid Use: A Retrospective Cohort Study of Medicare Patients Using Electronic Health Records
  Favorite
• P-021
  Olanzapine and Potential Risk of Somnambulism : A Systematic Review
  Favorite
• P-437
  Old Methods and New Data: A near Real-time Plan for Vaccine Surveillance and Signal Detection in the United States
  Favorite
• P-013
  Opioid Consumption from 2013 to 2016 in South Africa: Morphine, Pethidine, Oxycodone and Tramadol
  Favorite
• P-232
  Opioid Use Patterns Among Non-metastatic Cancer Survivors: A Systematic Literature Review
  Favorite
• P-418
  Optimization of Prescription Patterns: A Response to Control High Pharmaceutical Expenditure
  Favorite
• P-630
  Oral Bisphosphonate Exposure Among Denosumab Users in Ontario, Canada
  Favorite
• P-350
  Overdose Risk Following Prescription Benzodiazepine Treatment in Young People
  Favorite
• P
• P-439
  Paediatric Outpatient Prescriptions in Countries with Advanced Economies in the 21st Century: A Systematic Review and an International Comparison
  Favorite
• P-024
  Papillomavirus Vaccination and Guillain-barre Syndrome Among Girls: A Population-based Study in Spain
  Favorite
• P-195
  Parkinson's Disease Experience from a Patient's Perspective: Systematic Review on Patient Reported Outcomes
  Favorite
• P-192
  Patient Characteristics, Pain Treatment Patterns, and Incidence of Total Joint Replacement in a Population with Osteoarthritis
  Favorite
• P-601
  Patterns and Predictors of Stimulant Use During Pregnancy
  Favorite
• P-178
  Patterns of Antihypertensive Drugs Use After Primary Stroke in the General Population
  Favorite
• P-494
  Patterns of Antimicrobial Prescribed to Patients Admitted to a Tertiary Care Hospital in South-west Nigeria: A Prescription Quality Audit
  Favorite
• P-153
  Patterns of Meropenem Utilization and Resistance at a Kenyan Public Referral Hospital
  Favorite
• P-369
  Patterns of Prescription and Co-prescription of Opioids and Benzodiazepines in the Period 2010 to 2018: A Real-world, Population-based Study
  Favorite
• P-533
  PD-1 Immune Checkpoint Inhibitors and Serious Immune-related Adverse Events
  Favorite
• P-206
  Pediatric Fentanyl Overdose Within an Electronic Health Record Database
  Favorite
• P-308
  Penetration Rate of Anti-tnf Biosimilars in Hospitals in France: 5 Years Status
  Favorite
• P-346
  Periodic Safety Reporting System for Post-market Drug Safety: A Comparative Analysis of Europe, United States, Japan and Korea
  Favorite
• P-495
  Persistence to Treatment After Percutaneous Coronary Intervention for Acute Coronary Syndrome Patients as a Cost-saving Opportunities in Indonesia
  Favorite
• P-198
  Pharmacist-led Intervention to Support Deprescribing of Cardiometabolic Medication Among People with Type 2 Diabetes: A Pilot Study
  Favorite
• P-553
  Pharmacists Role in Patient Safety: Evaluation of Dispensing Errors in a Regional Hospital
  Favorite
• P-082
  Pharmacoepidemiology and Ethics
  Favorite
• P-335
  Pilot Study Rectifies Real World Study Design to Support Regulatory Decision Making
  Favorite
• P-244
  Polypharmacy Among Older Individuals with Heart Failure: Trends Between 2000 and 2017 in the Province of Quebec, Canada
  Favorite
• P-402
  Polypharmacy and Health-related Quality of Life in Older Adults with Cancer: Determining Breakpoints
  Favorite
• P-355
  Polypharmacy and Outpatient Attendance of People with Schizophrenia in Indonesia
  Favorite
• P-327
  POPPY II Cohort Profile– a Population-based Linked Cohort Examining the Course and Outcomes of Prescription Opioid Use in NSW, Australia, 2003-2018
  Favorite
• P-060
  Post-keratoplasty Fungal Keratitis in the Sentinel Distributed Database: Prevalence and Time Trends
  Favorite
• P-362
  Post-marketing Drug Safety Sources: An Evaluation of the Fda’s Drug Safety Communications
  Favorite
• P-187
  Potentially Inappropriate Medication Use in Older Hospitalized Patients with Type 2 Diabetes: A Cross-sectional Study
  Favorite
• P-485
  Predictors of Concomitant Use of Opioids and Gabapentin in the National Alzheimer's Coordinating Center Database
  Favorite
• P-137
  Predictors of Length of Stay, Mortality and Outcomes Among Hospitalised COVID-19 Patients In saudi Arabia
  Favorite
• P-144
  Pregnancy and fetal outcomes following maternal exposure to Glatiramer Acetate
  Favorite
• P-538
  Pregnancy and Neonatal Outcomes Associated with Opioid Assisted Treatments and Unexposed Pregnancies
  Favorite
• P-393
  Pregnancy in Women with Heart Failure: A Cross-sectional Study in the Sentinel System
  Favorite
• P-579
  Prenatal Exposure to Psychotropic Medications and the Risk of Seizure in Children: A Population-based Cohort Study
  Favorite
• P-143
  Prescribing Patterns of Lipegfilgrastim in EU: A Retrospective Study
  Favorite
• P-324
  Prescribing Trends of Antihypertensive Drug Classes in a Hong Kong Dementia Cohort
  Favorite
• P-603
  Prescription Drug-based Risk Scores: A Systematic Review
  Favorite
• P-461
  Prescription Opioid Use in Australian Women of Reproductive Age from 2013 to 2020
  Favorite
• P-049
  Prevalence and Factors Associated with Oral Anticoagulant Use in the General Nursing Home Population
  Favorite
• P-216
  Prevalence and Leaves Due to Long- and Short-term Disability and Workers' Compensation for Employees with Diabetes
  Favorite
• P-184
  Prevalence and Predictors of Potentially Inappropriate Psychotropic (PIP) Medications in Older Adults with Psychiatric Illness
  Favorite
• P-319
  Prevalence of Adverse Drug Reactions in the Primary Care Setting: A Systematic Review and Meta-analysis
  Favorite
• P-136
  Prevalence of Chronic Kidney Diseases in Patients with Diabetes Mellitus in the Middle East: A Systematic Review and Meta-analysis
  Favorite
• P-562
  Prevalence of Extramammary Paget’s Disease in Urban China: A Population-based Study
  Favorite
• P-185
  Prevalence of Potentially Inappropriate Medication and Its Correlates in Elderly Hospitalized Patients: A Cross‑sectional Study Based on Beers Criteria
  Favorite
• P-186
  Prevalence of Potentially Inappropriate Medication in Elderly Inpatients with Chronic Kidney Disease (CKD)
  Favorite
• P-092
  Primary Non-adherence in Primary Care in the Netherlands
  Favorite
• P-058
  Process Evaluation of Implementing a Pharmacist-led Intervention to Improve Adherence to Antihypertensive Drugs Among Patients with Type 2 Diabetes in Indonesian Community Health Centers
  Favorite
• P-130
  Prognostic Impact of Three Comorbidity Indices on 1 Year Mortality Among Patients with Hip Fracture
  Favorite
• P-379
  Propensity Score Modeling to Reduce Channeling Bias When Exposure Is Rare
  Favorite
• P-009
  Proton Pump Inhibitors and Risk of End Stage Renal Disease in Patients with Chronic Kidney Disease
  Favorite
• P-309
  Psoriasis Risk After Betablockers Exposure: Analysis of French Pharmacovigilance Data
  Favorite
• Q
• P-193
  Quality and Completeness of Diagnostic Codes for Myocardial Infarction in CPRD Aurum
  Favorite
• R
• P-214
  Real World Evidence in Effectiveness, Safety, and Cost Savings of Generic Levothyroxine: A Systematic Review
  Favorite
• P-145
  Real World Utilization of 91-day Extended Levonorgestrel-containing Combined Oral Contraceptives in Europe: A Multinational Database Study
  Favorite
• P-491
  Real- world Utilization of Octreotide Immediate Releasing Use with Octreotide Long-acting Releasing
  Favorite
• P-154
  Real-world Adherence of Nusinersen for the Treatment of Spinal Muscular Atrophy (SMA) Using US Electronic Health Records
  Favorite
• P-270
  Real-world Algorithms in Defining Castration Resistant Prostate Cancer in Retrospective Observational Studies
  Favorite
• P-256
  Real-world Treatment Patterns of Newly Diagnosed Patients with Asthma And/or COPD
  Favorite
• P-415
  Real-world Treatment Trajectories for Newly Diagnosed Type 2 Diabetes Mellitus in Patients with Metastatic Cancer
  Favorite
• P-565
  Recent Use of External Controls in Clinical Trials: A Pragmatic Literature Review
  Favorite
• P-375
  Remdesivir Safety Monitoring During the COVID-19 Pandemic: A Global Review of Adverse Drug Reaction (ADR) Reporting in Vigibase
  Favorite
• P-566
  Reporting of Pancreatitis with Tocilizumab Use: A Disproportionality Analysis Using the United States Food and Drug Administration Adverse Event Reporting System
  Favorite
• P-535
  Retinal Toxicity in a Multinational Inception Cohort of Systemic Lupus Patients on Hydroxychloroquine
  Favorite
• P-436
  Review of Sytemic Adverse Drug Reactions of Vascular Endothelial Growth Factor Inhibitors in French Pharmacovigilance Data Base
  Favorite
• P-077
  Risk Factors for Carbapenemase-producing Enterobacteriaceae Colonization: A Population Based Nested Case-control Study
  Favorite
• P-022
  Risk Factors for Thyroiditis Among Girls and Adolescents Scheduled to Human Papillomavirus Vaccination
  Favorite
• P-636
  Risk of Acute Respiratory Failure Among Non-elderly Patients with Solid Tumors Receiving Pegfilgrastim and Concomitant Opioids: A Nested Case-control Study
  Favorite
• P-323
  Risk of Cardiovascular Diseases Associated with Sulfonylurea as an Add-on Therapy to Metformin in Patients with Type 2 Diabetes Mellitus
  Favorite
• P-238
  Risk of Domperidone in Pregnant Women: A Study in the EFEMERIS Database
  Favorite
• P-466
  Risk of Emergency Department Visits or Hospitalization for Cardiovascular Events in Patients with Medical Cannabis Authorization
  Favorite
• P-002
  Risk of First Ischemic Stroke and Use of Antidopaminergic Antiemetics: A Case-time-control Study in France
  Favorite
• P-294
  Risk of Fracture Associated with SGLT-2 Inhibitors as an Add-on Therapy to Metformin in Patients with Type 2 Diabetes Mellitus
  Favorite
• P-604
  Risk of Hospitalization and Death Associated with Pimavanserin Use in Older Adults with Parkinson’s Disease
  Favorite
• P-098
  Risk of Intracranial Meningioma Requiring Surgical Intervention Among Recent Hormonal Contraceptives Users
  Favorite
• P-070
  Risk of Thrombotic Microangiopathy with Tyrosine Kinase Inhibitors: A Disproportionality Analysis from Vigibase and AERS Databases
  Favorite
• P-125
  Risk of Thyroid Cancer with the Use of GLP-1 Receptor Agonists
  Favorite
• P-441
  Risks of Cardiovascular and Kidney Events Associated with Proton Pump Inhibitor Use Among Medicare Beneficiaries: A Retrospective New User Cohort Study
  Favorite
• P-531
  Role of D-dimer on Serious Outcomes Among Patients Hospitalized with COVID-19
  Favorite
• S
• P-252
  Safety and Effectiveness of Rivaroxaban in First-time Users with Non-valvular Atrial Fibrillation in Routine Practice
  Favorite
• P-200
  Safety Evaluation of Panobinostat, Ixazomib, Elotuzumab, and Daratumumab Using FDA Adverse Event Reporting System (FAERS) Database 2015 – 2020
  Favorite
• P-423
  Safety of COVID-19 Vaccine: Knowledge of Staff at a Medical College in Western Nepal
  Favorite
• P-608
  Safety of Generic Cyclosporine in Solid Organ Transplant Patients: A Systematic Review and Meta-analysis
  Favorite
• P-146
  Safety of Ovaleap® (Follitropin Alfa) in Infertile Women Undergoing Superovulation for Assisted Reproductive Technologies (SOFIA): A Multinational Comparative, Prospective Cohort Study
  Favorite
• P-079
  Safety of Propofol Use in Children and Adolescents: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS)
  Favorite
• P-065
  Safety of Rivaroxaban in First-time Users Treated for Deep Vein Thrombosis and Pulmonary Embolism
  Favorite
• P-215
  Safety Profile Analysis of Sunitinib and Dasatinib Protein Kinase Inhibitors Using FDA Adverse Event Reporting System (FAERS) Database
  Favorite
• P-020
  Safety Review of Vemurafenib and Potential Risk of Hyperglycemia: A Systematic Review and Analysis of Individual Case Safety Reports in the WHO Global Database
  Favorite
• P-041
  Scope of Insulin Human Utilization in Females of Childbearing Age in the US
  Favorite
• P-074
  Sex Difference, Label Indications and Trend in Atypical Antipsychotics Use in Early-onset Schizophrenia: A Nationwide Cross-sectional Study
  Favorite
• P-008
  Sex Differences in Lipid Profile Across the Life Span in Patients with Type 2 Diabetes: A Cross-sectional Study
  Favorite
• P-610
  Short-term Incidence of Thrombotic Events in Patients Who Were Treated with Factor Xa Inhibitors and Hospitalized for Bleeding
  Favorite
• P-567
  SIGMA Consortium: A New Era of Collaboration to Study the Safety and Effectiveness of Medical Interventions
  Favorite
• P-001
  Signal Detection by Time-to-onset Method in Conjunction with Disproportionality Analysis: A Study of Spontaneous Reports from Japan
  Favorite
• P-110
  Signal Detection of Zoster Vaccine Adverse Event in Elderly Using Korea Adverse Event Reporting System Database (KAERS)
  Favorite
• P-010
  Slovenia versus the Netherlands: A Comparison of Opioid Prescription Strategies
  Favorite
• P-334
  Socioeconomic Status and Prognosis in Premenopausal Breast Cancer: A Population-based Cohort Study in Denmark
  Favorite
• P-151
  Socio-epidemiological Approaches in Designing and Modelling Pharmacy Public Health Programs in Infectious Diseases Control in Developing Countries
  Favorite
• P-006
  Stroke Risk Associated with Incident Antidepressant Use: Delineated with Age
  Favorite
• P-348
  Study Validity in Sports Medicine: A Quantitative Assessment of Orthopedic Research Based on Publicly-obtained Data
  Favorite
• P-507
  Suicide Risk in Schizophrenia Across the Lifespan
  Favorite
• P-498
  Sulfonylureas and the Risk of Ventricular Arrhythmias Among Patients with Type 2 Diabetes: A Systematic Review of Observational Studies
  Favorite
• P-213
  Surveillance of Postmarketing Risk-mitigation Behavior Using Tests of Model Misspecification in a Statistical Process Control Framework
  Favorite
• P-557
  Survival Analysis of ICU Patients Administered Human Albumin Infusion from the MIMIC III v1.4 Database
  Favorite
• P-556
  Survival Analysis of N-acetylcysteine Administration in ICU Patients from the MIMIC III v1.4 Database
  Favorite
• P-028
  Survival in Older Adults Treated for Chronic Lymphocytic Leukemia Compared to Those Without Cancer: An Exploratory Time-trend Analysis
  Favorite
• P-371
  Swedish covid-19 Investigation for Future Insights – a Population Epidemiology Approach Using Register Linkage (SCIFI- PEARL)
  Favorite
• P-203
  Systematic Literature Review (SLR) of Respiratory Syncytial Virus (RSV) Burden and Health Care Utilization (HCU) Among Infants in the United States (US)
  Favorite
• P-168
  Systematic Review and Meta-analysis: Efficacy and Safety of Medical Cannabis in Children
  Favorite
• P-457
  Systematic Review of Prospective Pregnancy Studies in Europe: Scope for Improvement
  Favorite
• P-456
  Systemic Lupus Erythematosus in a Large, Longitudinal Electronic Health Record Database: Demographics, and Comorbidities - A Focus on African Americans
  Favorite
• T
• P-537
  Temporal and Hospital-level Variation in High-dose Postpartum Opioid Prescribing After Cesarean Delivery
  Favorite
• P-384
  Temporal Changes in the Baseline Patient Characteristics of COVID-19 Patients
  Favorite
• P-280
  Temporal Trends in Medication Utilization Among Hospitalized COVID-19 Patients
  Favorite
• P-523
  Temporal Trends of Pharmacologic Treatments for tuberculosis and Multidrug-resistant tuberculosis Following Treatment Guideline Dissemination in South Korea
  Favorite
• P-443
  Teratogenicity Associated with Antibiotic Therapy; A Disproportionality Analysis in Spontaneous Reporting Database
  Favorite
• P-483
  Test-negative Designs Applied to COVID-19 Vaccine Effectiveness Assessment: Methodological Challenges
  Favorite
• P-169
  The Association Between Proton Pump Inhibitors and Increased Risk of Hyponatremia - A Cohort Study
  Favorite
• P-539
  The Association Between Trajectories of Use of Systemic Agents and Depression in Patients with Psoriasis: A Sequence and Cluster Analysis
  Favorite
• P-540
  The Association Between Type 2 Diabetes and Cancer Incidence in the United Kingdom Between 1988 and 2019
  Favorite
• P-208
  The Disease-modifying Drugs for Multiple Sclerosis and Subsequent Health Service Use: A Population-based Study
  Favorite
• P-260
  The Effect of Aspirin on COPD: A Methodological Review of the Observational Studies
  Favorite
• P-326
  The Effect of Prescriber, Treatment, and Client Characteristics on Retention in Opioid Agonist Treatment: A 15-year Retrospective Cohort Study
  Favorite
• P-410
  The Effectiveness of a Module for Primary Health Care Professionals in Preventing Nonsteroidal Anti-inflammatory Drugs-associated Gastrointestinal Adverse Reactions Among Elderly
  Favorite
• P-364
  The Establishment of Regional Pharmacovigilance (PV) Centers in Saudi Arabia
  Favorite
• P-188
  The Global Burden of Upper and Lower Gastrointestinal Bleeding in General Population: A Systematic Review
  Favorite
• P-333
  The Impact of COVID-19 on Telemedicine Use and Patients’ Characteristics
  Favorite
• P-543
  The Incidence Rates of Hepatobiliary Diseases Among Non-alcoholic Steatohepatitis Patients Stratified by fibrosis-4 (FIB-4) Index for Liver Fibrosis
  Favorite
• P-158
  The Influence of Medical Representative Visits on Prescribing Practice of Physicians in Jordan and Iraq: A Cross-sectional Study
  Favorite
• P-367
  The Patterns of Spontaneous Reports of Neurologic, Hematologic, and Immunologic Adverse Events Following Immunization in Korea
  Favorite
• P-420
  The Prevalence and Associated Risk Factors of Perfumes Sensitivity in Saudi Arabia
  Favorite
• P-613
  The Risk of Severe Acute Kidney Injury with Use of Anti-hypertensives in the Elderly: A Self-controlled Case Series Analysis
  Favorite
• P-126
  The Use of Lag Times in Cancer Pharmacoepidemiology
  Favorite
• P-152
  The Use of Medication Among People with Stage 2 Hypertension: Findings from an Indonesian Cross-sectional Study
  Favorite
• P-440
  The Use of Real-world Data in Research in the GCC Countries: A Descriptive Study
  Favorite
• P-257
  The Use of Uncertain Exposure – a Method to Define switching and Add-on in Pharmacoepidemiology
  Favorite
• P-555
  The Utility of Non-specific ICD-10 Z3A Codes in Estimating Gestational Age
  Favorite
• P-328
  The Utilization Evaluation of Intravenous Pantoprazole for Stress Ulcer Prophylaxis in a Major Teaching Hospital
  Favorite
• P-034
  Thrombotic and Cardiovascular Events Among Patients Hospitalized with COVID-19: Findings from a Large EHR Database
  Favorite
• P-314
  Time Trends in Patient Characteristics of New Rivaroxaban (RVX) Users with Atrial Fibrillation (AF) Across Four Countries
  Favorite
• P-172
  Tocilizumab Induced Adverse Events in covid-19 Patients: Exploration of Reports Submitted to US FDA Adverse Event Reporting System (FAERS)
  Favorite
• P-521
  Towards OS approximation in early clinical trials using Prognostic Scores
  Favorite
• P-366
  Trajectories of Corticosteroid Dosing Pattern Among Patients with Systemic Lupus Erythematosus
  Favorite
• P-085
  Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy)
  Favorite
• P-464
  Transcatheter and Surgical Aortic Valve Replacement: Patient Characteristics and Outcomes
  Favorite
• P-297
  Trastuzumab Related Cardiotoxicity in Breast Cancer
  Favorite
• P-398
  Treatment Patterns and Appropriateness of Antipsychotic Prescriptions in Patients with Schizophrenia
  Favorite
• P-529
  Treatment Trajectory of Antihypertensive Drugs in UK Primary Care Practices
  Favorite
• P-559
  Trends and Patterns in Traditional Chinese Medicine Use Among Chinese Population in Late Adulthood: An Eight-year Repeated Panel Survey
  Favorite
• P-228
  Trends from 2001 to 2019 in Workers Compensation Indemnity Payments and Absences Among Employees with Bone Diseases, Headaches/migraines, Diabetes, Multiple Sclerosis, Osteoarthritis, Rheumatoid Arthritis and Back Pain
  Favorite
• P-219
  Trends in Absence Time and Payments Due to Long- and Short-term Disability and Workers' Compensation for Employees with Osteoarthritis
  Favorite
• P-221
  Trends in Absence Time and Payments Due to Long- and Short-term Disability and Workers' Compensation for Employees with Rheumatoid Arthritis
  Favorite
• P-207
  Trends in Administered Medication Use Among Patients Hospitalized with COVID-19 in the United States
  Favorite
• P-063
  Trends in Antipsychotic Dispensation to Residents of Long-term Care Facilities in Nova Scotia, Canada Including After a Fall-related Hospitalization
  Favorite
• P-513
  Trends in Hydroxychloroquine Drug Utilization and Safety in 2020
  Favorite
• P-218
  Trends in Leaves Due to Long- and Short-term Disability and Workers' Compensation for Employees with Back Pain
  Favorite
• P-320
  Trends in Prescribing of Non-steroidal Anti-inflammatory Medications in the US Ambulatory Care Setting, 2006-2016
  Favorite
• P-066
  Trends in the Management of Primary Headache in US Emergency Departments: Analysis of 2007-2018 NHAMCS Data
  Favorite
• P-165
  Trends of Anti-epileptic Drugs Use During Pregnancy in Manitoba, Canada: A 20-year Utilization Study
  Favorite
• P-016
  Triglyceride Levels in Early Type 2 Diabetes and Their Association with Cardiovascular Risk: A Danish Cohort Study
  Favorite
• U
• P-118
  Understanding Oral Anticoagulant Preferences of Patients with Atrial Fibrillation in China and Willingness-to-pay: Evidence from a Discrete Choice Experiment
  Favorite
• P-560
  Urban Prevalence of Multiple Sclerosis in China: A Population-based Study in Six Provinces
  Favorite
• P-205
  Use and Performance of Brighton Collaboration Case Definitions in Low-middle Income Settings
  Favorite
• P-427
  Use of and Adherence to Bisphosphonates in Elderly Patients with Complex Health Needs: An Analysis of UK Primary Care Records
  Favorite
• P-204
  Use of Beta Blockers and Death from Breast Cancer in New Zealand Breast Cancer Patients
  Favorite
• P-616
  Use of High-dimensional Propensity Scores (hdPS) in a Japanese National Claims Database
  Favorite
• P-497
  Use of Knowledge Bases in Medical Education: Medical Students’ Perspective
  Favorite
• P-617
  Use of Natural Language Processed Clinical Notes in an Electronic Health Record (EHR) to Characterize Adverse Events of Mood Disorders
  Favorite
• P-245
  Use of Non-insulin Antidiabetic Drugs in Children and Young Adults – a Scandinavian Drug Utilization Study from 2010-2019
  Favorite
• P-618
  Use of Potential Nephrotoxic Medications Among Adults with CKD: Parallel Cohort Studies in U.S. and Swedish Routine Care
  Favorite
• P-191
  Use of Potentially Inapropriate Medicines by Elderly People in Primary Care of the Unified Health System (SUS) in Brazil
  Favorite
• P-475
  Use of prescribed drugs to treat frequent conditions during pregnancy in outpatient care in Switzerland: Analysis of Swiss health care claims data
  Favorite
• P-617
  Use of Renin-angiotensin-aldosterone System Inhibitors and the Risk of Acute Pancreatitis
  Favorite
• P-377
  Users of Biologics for Crohn’s Disease and Ulcerative Colitis in the Netherlands
  Favorite
• P-141
  Using Administrative Data and the Regional Pathology Registry of Tuscany to Describe First-line Pharmacotherapy and Survival of Patients with Non-resectable Non-small Cell Lung Cancer from 2009 to 2019
  Favorite
• P-573
  Using Negative Control Outcomes to Assess the Comparability of Treatment Groups Among Postmenopausal Women Switching Osteoporosis Therapy
  Favorite
• P-618
  Using Structural Topic Modelling to Reveal Patterns in Reports on Opioid Drugs in a Pharmacovigilance Database
  Favorite
• P-389
  Utilisation and Safety of Glycopyrronium Bromide (GPB) Oral Solution for the Treatment of Sialorrhoea in Children <18 Years in the UK
  Favorite
• P-625
  Utilization and Long-term Persistence of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Liver Disease
  Favorite
• P-472
  Utilization of Anti-cgrp Monoclonal Antibodies for Migraine Prophylaxis Between 2019 and 2020 in Tuscany Region, Italy
  Favorite
• P-414
  Utilization of Drugs Reimbursed by the Italian Healthcare Service for the Treatment of COVID19 During the First Pandemic Wave: Gender Differences in the General and Nursing Home Population of Tuscany
  Favorite
• P-634
  Utilization Pattern of Antipsychotics in Patients with Dementia
  Favorite
• P-409
  Utilization Patterns and Healthcare Accesses of Jaki Used in Rheumatoid Arthritis Patients in Tuscany: The LEONARDO Study
  Favorite
• P-357
  Utilization Patterns of Direct Oral Anticoagulants in Medicare Beneficiaries with Cancer and Non-valvular Atrial Fibrillation
  Favorite
• P-313
  Utilizing a Structured Benefit-risk Assessment to Evaluate a Combination of Olanzapine and Samidorphan for the Treatment of Schizophrenia and Bipolar I Disorder
  Favorite
• V
• P-080
  Validation of Self-reported Medication Use Applying Untargeted Mass Spectrometry-based Metabolomics Techniques in the Rhineland Study
  Favorite
• P-054
  Validation Test for Algorithms to Identify Rheumatoid Arthritis Patients in the Tuscan Healthcare Administrative Databases
  Favorite
• P-037
  Vaporized Nicotine (E-cig) Use Among People with HIV in Care in the US
  Favorite
• P-347
  Variation Among Pharmacists in Calculating Days’ Supply
  Favorite
• P-619
  Venous Thromboembolism in Patients with Chronic Inflammatory Skin Diseases
  Favorite
• P-075
  Visualization Methods to Examine Treatment Patterns in Pharmacoepidemiology: An Example Using Osteoporosis Medications
  Favorite
• W
• P-626
  What Is Time Zero for Treatment Among Hospitalized Patients with Bacteremia?
  Favorite
• Y
• P-239
  Yellow Fever Vaccine Usage in Three United States Healthcare Databases and Risk of Neurotropic Disease and Viscerotropic Disease in Vaccinees
  Favorite
• Z
• P-300
  Zolpidem, Zopiclone and Zaleplon Induce Complex Sleep Behaviors
  Favorite